ArticleBMC gastroenterology2026

Platelet P2Y12 inhibitor use and risk of colorectal cancer incidence and colorectal cancer-related mortality: a Swedish registry-based cohort study.

Michael Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.